Latest stories on ALLR
Allarity Therapeutics Announces Strategic Capital Allocation for Filing of SPAC Registration Statement
GlobeNewswire56 · neutralgeneral
Allarity Therapeutics Announces Strategic Capital Allocation for Filing of SPAC Registration Statement
Business Insider56 · neutralgeneral
Allarity Acquisition Corp. Files for IPO
MarketWatch55 · neutralgeneral
Allarity Therapeutics, Inc. (ALLR) files 8-K
SEC 8-K50 · neutralgeneral
Allarity Therapeutics reports Q2 results
Seeking Alpha52 · neutralearnings
Allarity Therapeutics Reports Second Quarter 2026 Results and Completion of the Phase 3-Ready Stenoparib Manufacturing Campaign
Business Insider56 · neutralproduct/pr
Allarity Therapeutics Reports Second Quarter 2026 Results and Completion of the Phase 3-Ready Stenoparib Manufacturing Campaign
GlobeNewswire56 · neutralearnings
Allarity Wins Key U.S. Patent for Stenoparib Diagnostic
TipRanks63 · neutralproduct/pr
Allarity Therapeutics, Inc. (ALLR) files 8-K
SEC 8-K50 · neutralgeneral
Allarity Therapeutics, Inc. (ALLR) Shareholder/Analyst Call Prepared Remarks Transcript
Seeking Alpha50 · neutralgeneral
Allarity Therapeutics, Inc. (ALLR) files 8-K
SEC 8-K50 · neutralgeneral
Allarity Therapeutics Updates CEO Management and Compensation Agreement
TipRanks50 · neutralgeneral
Allarity Therapeutics GAAP EPS of -$0.17 beats by $0.05
Seeking Alpha56 · neutralearnings